drugset / Trial / NCT02365870

Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment

NCT02365870

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.

Timeline

Start
2016-08
Primary completion
2019-07
Completion
2019-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rotigotine Unknown 2 mg Other
Comparator Rotigotine Unknown 6 mg Other